Early Detection of Parkinson's Disease a Step Closer

The battle to tackle chronic and progressivechanges in individual neurons in brain cells which
Parkinson's disease (PD) has been boosted withproduce dopamine before PD destroys them.
encouraging news of pioneering research work whichThis is done by effectively mapping the position and
could help diagnose the condition at a much earlierform of metal ions, mainly iron, in the key regions of
stage.the brain where Parkinson's develops.
At present when a clinical diagnosis of Parkinson's isThis now opens up the real possibility of earlier
made, based on observation of symptoms such asintervention in this neurodegenerative disease by
muscle rigidity, tremor in the hands, feet and jaw,applying this technique to scanning technologies such
and worsening balance and posture, serious damageas MRI. With such a diagnosis of early onset PD
has already been done in the nerve cells of the brain.clinicians would be able to use the latest drug
At this stage the loss of the key neurotransmittertherapies which could help slow down the irreversible
chemical dopamine, which carries electrical signals inprocess of cell destruction, which then results in the
the brain, leads to a significant change in the delicatecommon clinical symptoms.When you consider that
brain chemical balance with acetylcholine. Major nervethere are over 4 million people worldwide who suffer
cell death in the substantia nigra region will havefrom this progressive, chronic condition, the potential
already occurred, with loss of over 80 per cent ofimpact of this work is highly significant.
the dopamine-producing neurones.Data show that Parkinson's affects around 1% of
Leading edge research by a team of scientists atpeople over 60, with the onset of first symptoms
Keele University in England, collaborating withoccurring around this age. Medical practitioners then
colleagues at the University of Florida, uses datahave to use the range of interventions to maintain
collected from a Diamond Light Source synchrotronthe best quality of life for their patients.
at Harwell, Oxfordshire.This potential revolutionary diagnostic technique
Using this Diamond Light Source particle acceleratorwould mean clinicians have an advanced warning of
the research team focuses light, which has theParkinson's disease and the ability to choose from a
intensity equivalent to a million watt bulb, into a beamcombination of drug intervention, physiotherapy and
as small as the width of a single cell. With thisdeep brain stimulation techniques at an earlier stage,
technique the scientists are able to show up keyand so make them more effective.